Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...
Source: prnewswire.com